Imaging Criteria for Treatment Response in Immuno-oncology Clinical Trials
Partner Content
Immunotherapies enhance patients’ endogenous immune system function of attacking tumor cells, and are being widely and successfully used in the field of immuno-oncology. Adoption of assumptions based on more traditional chemotherapy-based responses can lead to significant operational difficulties and inaccurate interpretation of responses. To that end, it is important to choose the appropriate clinical response and imaging criteria.
Read QuintilesIMS's white paper Imaging Criteria for Treatment Response in Immuno-oncology Clinical Trials to learn more about the important recording practices needed in these unique trials.
For further content relating to immuno-oncology trials please click here.
